Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2025 Jun 4:15:1543590.
doi: 10.3389/fonc.2025.1543590. eCollection 2025.

The role of MYEOV gene: a review and future directions

Yidan Xi #  1 , Xuefei Liu  1 , Yanan Ge #  1 , Mingzhe Jiang  1 , Dong Zhao  1 , Ershu Zhao  1 , Fei Cai  1 , Xinlong Wang  1 , Jiatong Li  2 , Tingting Li  1 , Zhendong Zheng  1
Affiliations
Review

The role of MYEOV gene: a review and future directions

Yidan Xi et al. Front Oncol. .

Abstract

The overexpressed gene MYEOV in multiple myeloma, as an oncogene, has been widely recognized for its high expression levels in various malignant tumors. MYEOV plays a significant role in multiple malignancies, particularly in diseases such as multiple myeloma, breast cancer, lung cancer, pancreatic cancer, and esophageal cancer. The presence of the open reading frame of MYEOV in humans and other primates suggests its potential protein-coding capacity, although direct evidence of functional MYEOV protein is currently lacking. The role of MYEOV in various tumors is not limited to its direct effects as an oncogene; it also includes its complex role in tumor cell signaling pathways and its ability to participate in miRNA regulatory networks as a competing endogenous RNA (ceRNA). Studies have shown that MYEOV may affect the expression of cancer-related genes through enhancer activity. This article aims to provide a comprehensive review of the role of MYEOV, its involvement in signaling pathways in tumor cells, and the latest advancements in MYEOV-targeted therapies.

Keywords: MYEOV; biomarker therapy; signaling pathway; target; tumor.

PubMed Disclaimer

Conflict of interest statement

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Figures

Figure 1
Figure 1
Mechanism of MYEOV promoting tumor proliferation and metastasis.
See this image and copyright information in PMC

Similar articles

See all similar articles

References

    1. Fakhar AZ, Liu J, Pajerowska-Mukhtar KM, Mukhtar MS. The lost and found: unraveling the functions of orphan genes. J Dev Biol. (2023) 11:27. doi: 10.3390/jdb11020027 - DOI - PMC - PubMed
    1. Janssen JW, Vaandrager JW, Heuser T, Jauch A, Kluin PM, Geelen E, et al. Concurrent activation of a novel putative transforming gene, myeov, and cyclin D1 in a subset of multiple myeloma cell lines with t(11;14)(q13;q32). Blood. (2000) 95:2691–8. - PubMed
    1. Davidson BSA, Arcila-Galvis JE, Trevisan-Herraz M, Mikulasova A, Brackley CA, Russell LJ, et al. Evolutionarily conserved enhancer-associated features within the MYEOV locus suggest a regulatory role for this non-coding DNA region in cancer. Front Cell Dev Biol. (2024) 12:1294510. doi: 10.3389/fcell.2024.1294510 - DOI - PMC - PubMed
    1. Liang E, Lu Y. MYEOV increases HES1 expression and promotes pancreatic cancer progression by enhancing SOX9 transactivity. Erratum in: Oncogene. (2020) 39:6437–50. doi: 10.1038/s41388-020-01443-4 - DOI - PubMed
    1. Janssen JW, Cuny M, Orsetti B, Rodriguez C, Vallés H, Bartram CR, et al. MYEOV: a candidate gene for DNA amplification events occurring centromeric to CCND1 in breast cancer. Int J Cancer. (2002) 102:608–14. doi: 10.1002/ijc.v102:6 - DOI - PubMed

LinkOut - more resources